First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
What are controlled substances and their regulations? The Controlled S
Q2 CASUALTY REPORT 2024
Utilization Review (UR) plays a crucial role in the workers' compensation system, ensuring that medical treatments provided to injured employees ar
New report reveals current trends for P&C industry SAN DIEGO, Calif.—Medical costs nationally have risen 11% in workers
Each quarter, Enlyte publishes its medical price index (MPI), which analyzes Enlyte’s medical bill review professional services charge data for tre